Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harmony Biosciences Holdings (HRMY) Other financing activities: 2019-2021

  • Harmony Biosciences Holdings' Other financing activities was N/A to $5,000 in Q4 2021 from the same period last year, while for Dec 2021 it was $6.7 million, marking a year-over-year change of. This contributed to the annual value of $3.0 million for FY2023, which is N/A change from last year.
  • According to the latest figures from Q4 2021, Harmony Biosciences Holdings' Other financing activities is $5,000, which was down 70.59% from $17,000 recorded in Q3 2020.
  • Over the past 5 years, Harmony Biosciences Holdings' Other financing activities peaked at $5.8 million during Q1 2020, and registered a low of $5,000 during Q4 2021.
  • Over the past 3 years, Harmony Biosciences Holdings' median Other financing activities value was $446,000 (recorded in 2019), while the average stood at $1.7 million.